VagusNerve.com

TENS Units vs Vagus Nerve Stimulation: Different Technologies, Different Targets

TENS units and vagus nerve stimulators are both electrical devices, but they target entirely different parts of the nervous system and serve fundamentally different purposes. A TENS unit delivers current to peripheral sensory nerves near the skin surface, primarily for pain relief. A vagus nerve stimulation (VNS) device targets the vagus nerve specifically — the tenth cranial nerve that regulates heart rate, digestion, inflammation, and mood. Confusing the two leads to wasted money and misplaced expectations, so understanding what each device actually does matters.

What a TENS Unit Actually Does

TENS stands for transcutaneous electrical nerve stimulation. The device sends low-voltage electrical pulses through adhesive electrodes placed on the skin near an area of pain. The primary mechanism is gate control theory, proposed by Melzack and Wall in 1965: stimulating large-diameter A-beta sensory fibres (which carry touch and vibration) at the spinal cord level can inhibit the transmission of pain signals carried by smaller A-delta and C fibres. Higher-intensity TENS may also trigger endorphin release, providing a secondary analgesic effect.

TENS targets whatever peripheral sensory nerves lie beneath the electrodes. It does not selectively activate the vagus nerve, and the electrical parameters — typically 2–150 Hz, 50–250 microsecond pulse width — are designed for somatic pain modulation, not autonomic regulation. TENS is widely used for musculoskeletal pain, post-surgical pain, and labour pain, with variable evidence depending on the condition.

What Vagus Nerve Stimulation Does

VNS targets the vagus nerve — a specific cranial nerve running from the brainstem through the neck and into the thorax and abdomen. Because the vagus nerve regulates the parasympathetic nervous system, inflammation, and multiple brain circuits, stimulating it produces systemic effects that TENS cannot achieve. There are three main categories of VNS device:

Implanted VNS: A surgically placed electrode wraps around the left cervical vagus nerve, connected to a pulse generator in the chest. FDA-approved for drug-resistant epilepsy (since 1997) and treatment-resistant depression (since 2005). The RECOVER trial (2026, International Journal of Neuropsychopharmacology) studied approximately 500 patients with treatment-resistant depression across 84 US sites, finding that 69% of responders maintained their response at 12 months and over 80% at 24 months.

Non-invasive cervical VNS: The gammaCore Sapphire device delivers electrical stimulation through the skin of the neck over the cervical vagus nerve. It is FDA-cleared for acute treatment and prevention of migraine and cluster headache. The stimulation parameters are specifically calibrated for vagal activation, not general peripheral nerve stimulation.

Transcutaneous auricular VNS (taVNS): These devices stimulate the auricular branch of the vagus nerve (ABVN) in the ear. Peuker and Filler’s 2002 anatomical dissection study confirmed that the cymba conchae of the ear receives 100% of its sensory innervation from the ABVN, making it the most reliable target for non-invasive vagal stimulation. The tragus also contains ABVN fibres, though it shares innervation with the auriculotemporal nerve.

Your local vagus nerve experts

Find a vagus nerve practitioner near you

Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.

Or browse by approach

The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.

Why the Confusion Exists

Some manufacturers market TENS-like devices as “vagus nerve stimulators,” placing standard TENS electrodes on the neck or ear without the specific waveform parameters, electrode design, or anatomical targeting that characterise validated VNS devices. A TENS unit placed on the neck will stimulate whatever nerves and muscles lie beneath the electrodes — the sternocleidomastoid, superficial cervical plexus, and possibly some vagal fibres — but without controlled targeting, the stimulation is neither specific nor reproducible.

The distinction matters clinically. A 2022 systematic review of taVNS safety found that serious adverse events were extremely rare when devices specifically designed for auricular vagal stimulation were used, with common side effects limited to minor tingling, headache, and skin irritation at the electrode site. These safety profiles were established with purpose-built taVNS devices, not repurposed TENS units.

Matching the Device to the Goal

If the goal is localised pain relief in a specific body region — a sore knee, lower back pain, post-surgical discomfort — a standard TENS unit is the appropriate choice. It is inexpensive, widely available, and supported by moderate evidence for several pain conditions.

If the goal involves autonomic regulation — reducing inflammation, modulating mood, managing treatment-resistant epilepsy or depression, preventing migraine — then a device specifically designed for vagus nerve stimulation is required. For clinical conditions, the FDA-cleared options (implanted VNS for epilepsy and depression, gammaCore for headache) have the strongest evidence base. For general autonomic support, purpose-built taVNS devices that target the cymba conchae or tragus with appropriate parameters offer a non-invasive option, though research on many applications remains ongoing.

Using a TENS unit and calling it vagus nerve stimulation is like using a torch and calling it laser surgery — the energy delivery method shares superficial similarities, but the specificity, targeting, and clinical outcomes are entirely different.

Want to understand the full spectrum of vagus nerve stimulation methods and how they compare? Get My Vagus Nerve & Me eBook for a clear guide to the science behind every major VNS approach — from implanted devices to at-home ear stimulation.